2023
DOI: 10.3389/fnins.2023.1026939
|View full text |Cite
|
Sign up to set email alerts
|

Oxytocin receptors in the Magel2 mouse model of autism: Specific region, age, sex and oxytocin treatment effects

Abstract: The neurohormone oxytocin (OXT) has been implicated in the regulation of social behavior and is intensively investigated as a potential therapeutic treatment in neurodevelopmental disorders characterized by social deficits. In the Magel2-knockout (KO) mouse, a model of Schaaf-Yang Syndrome, an early postnatal administration of OXT rescued autistic-like behavior and cognition at adulthood, making this model relevant for understanding the actions of OXT in (re)programming postnatal brain development. The oxytoci… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 72 publications
0
2
0
Order By: Relevance
“…Magel2 was expressed in arcuate nucleus of hypothalamus, overlapping with vasopressin positive neurons 44 . The abnormality of Magel2 has been confirmed to be involved in neurological disease development 45 . Cybb is mainly expressed in granulocyte, and mouse brain microglia 46 .…”
Section: Discussionmentioning
confidence: 92%
“…Magel2 was expressed in arcuate nucleus of hypothalamus, overlapping with vasopressin positive neurons 44 . The abnormality of Magel2 has been confirmed to be involved in neurological disease development 45 . Cybb is mainly expressed in granulocyte, and mouse brain microglia 46 .…”
Section: Discussionmentioning
confidence: 92%
“…This is in apparent contrast to previous reports suggesting reduced OXT signaling contributes to heightened social fear (11,22,23). However, given that OXT receptors in Magel2 KO mice are downregulated (24), it is likely that the increased activity results from homeostatic compensation. A similar compensation is seen in PWS patients – while on one hand they report reduced methylation of OXT-receptor (25) and increased plasma OXT (26), treatment with OXT-receptor agonist improves symptoms of PWS in some clinical studies (2729) (but not others (30)).…”
Section: Discussionmentioning
confidence: 99%